317 related articles for article (PubMed ID: 30337536)
1. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
[TBL] [Abstract][Full Text] [Related]
2. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
3. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
4. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
5. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity.
Zhuang W; Li B; Long L; Chen L; Huang Q; Liang Z
Int J Cancer; 2011 Dec; 129(11):2720-31. PubMed ID: 21384342
[TBL] [Abstract][Full Text] [Related]
6. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy.
Zhuang W; Long L; Zheng B; Ji W; Yang N; Zhang Q; Liang Z
Cancer Sci; 2012 Apr; 103(4):684-90. PubMed ID: 22192169
[TBL] [Abstract][Full Text] [Related]
7. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
[TBL] [Abstract][Full Text] [Related]
8. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
[TBL] [Abstract][Full Text] [Related]
9. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
10. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
[TBL] [Abstract][Full Text] [Related]
11. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
12. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
13. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
[TBL] [Abstract][Full Text] [Related]
14. Selective calcium sensitivity in immature glioma cancer stem cells.
Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.
Sun P; Xia S; Lal B; Shi X; Yang KS; Watkins PA; Laterra J
BMC Cancer; 2014 Jun; 14():401. PubMed ID: 24893952
[TBL] [Abstract][Full Text] [Related]
17. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
[TBL] [Abstract][Full Text] [Related]
18. β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.
Feng HB; Wang J; Jiang HR; Mei X; Zhao YY; Chen FR; Qu Y; Sai K; Guo CC; Yang QY; Zhang ZP; Chen ZP
Stem Cells Transl Med; 2017 Mar; 6(3):830-839. PubMed ID: 28297578
[TBL] [Abstract][Full Text] [Related]
19. Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.
Wu CX; Xu A; Zhang CC; Olson P; Chen L; Lee TK; Cheung TT; Lo CM; Wang XQ
Mol Cancer Ther; 2017 Aug; 16(8):1531-1543. PubMed ID: 28522590
[TBL] [Abstract][Full Text] [Related]
20. Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway.
Hai L; Zhang C; Li T; Zhou X; Liu B; Li S; Zhu M; Lin Y; Yu S; Zhang K; Ren B; Ming H; Huang Y; Chen L; Zhao P; Zhou H; Jiang T; Yang X
Cell Death Dis; 2018 Feb; 9(2):158. PubMed ID: 29410396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
